Price
No data yet.
Social Signal Score
Analyst Ratings
1 analystRevenue
$615.0KAnalyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Eric Schlorff
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 18
- Beta
- -1.03
- Country
- US
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- -28.70
Financials
Revenue
$615.0K+804.4%Net Income
$-3.73MEBITDA
$-3.71MFree Cash Flow
$-2.99MEPS (diluted)
$-0.91Shares Outstanding (diluted)
4.08M+7729.7%Operating Expenses
$4.35MCash & Debt
$6.96MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.23M | $-12.15M | $-5.86 |
| 2024 | $135.0K | $-24.83M | $-66.30 |
| 2023 | $0.00 | $-26.23M | $-302.62 |
| 2022 | $0.00 | $-12.19M | $-233.80 |
| 2021 | $0.00 | $-4.60M | $-88.10 |
| 2020 | $0.00 | $-3.28M | $-0.10 |
Valuation
ICUhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
80-33.33%Social Signal Score
Mentions (7)
- Newsglobenewswire.com·1d ago·Negative
…l Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds DENVER, Oct. 05, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life, today announced the entry into definitive agreements on October 2, 2026, for the immediate exercise of certain outstanding warrants to purchase up to an agg…
View source ↗ - Newsglobenewswire.com·4d ago·Negative
SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026 DENVER, Oct. 02, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life announced today that a late-breaking abstract evaluating the results of the post-approval SAVE Registry data has been accepted for a special late-breaker poster presentation at …
View source ↗ - Newsglobenewswire.com·7d ago·Neutral
SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026 Dr. Chung to deliver an oral presentation highlighting QUELIMMUNE ® , an advanced extracorporeal therapy for critically ill pediatric patients with acute kidney injury (AKI)
View source ↗ - Newsglobenewswire.com·12d ago·Neutral
SeaStar Medical Congratulates H. David Humes, M.D. Prestigious honor recognizes Dr. Humes' pioneering work in developing the Selective Cytopheretic Device (SCD) therapy, commercialized by SeaStar Medical as QUELIMMUNE ® for critically ill pediatric patients with acute kidney injury (AKI)
View source ↗ - Newsglobenewswire.com·26d ago·Neutral
Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah's Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU Quoin Pharmaceuticals releases a new NETHERTON NOW video featuring Laura Wright-Sexton, MD, who first met her daughter Aminah as a patient in the ICU.
View source ↗ - Newsglobenewswire.com·40d ago·Neutral
ICU Medical to Participate in Upcoming Investor Conferences SAN CLEMENTE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences: Wells Fargo 21st Annual Healthcare Conference on September 9-10, 2026 Company management will attend the Wells Fargo 21st Annual Healthcare Conference, held at the Encore Boston Harbor in Boston,…
View source ↗ - Newsseekingalpha.com·54d ago·Positive
SeaStar Medical Holding Corporation (ICU) Q2 2026 Earnings Call Transcript SeaStar Medical Holding Corporation (ICU) Q2 2026 Earnings Call Transcript
View source ↗
Earnings
Thu, Nov 12(in 5 weeks)
Consensus estimate $-0.95 per share
Typical surprise +13.3% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 12$-0.91 vs $-0.97beat
- Wed, May 13$-0.90 vs $-0.73miss
- Wed, Mar 25$-0.80 vs $-0.97beat
- Thu, Nov 13$-1.30 vs $-1.50beat
- Wed, Aug 13$-1.80 vs $-4.30beat
- Wed, May 14$-4.40 vs $-5.20beat
Estimates and results for ICU via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ICU officers and directors.
- Bought
- $312k
- Sold
- —
23 trades
0 trades
- Messinger Michaelbought
- Baird Jennifer Abought
- Messinger Michaelbought
- Van Heel Kennethbought
- Van Heel Kennethbought
- Chung Kevinbought
- Baird Jennifer Abought
- Neuman Johnbought
77 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in ICU.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.